Pages that link to "Q20675614"
Jump to navigation
Jump to search
The following pages link to Radhe Mohan (Q20675614):
Displaying 50 items.
- Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants? (Q28654979) (← links)
- Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort (Q30664267) (← links)
- Determining the incident electron fluence for Monte Carlo-based photon treatment planning using a standard measured data set. (Q30789916) (← links)
- Reference photon dosimetry data and reference phase space data for the 6 MV photon beam from varian clinac 2100 series linear accelerators (Q30983094) (← links)
- Displacement-based binning of time-dependent computed tomography image data sets (Q31032572) (← links)
- Design of respiration averaged CT for attenuation correction of the PET data from PET/CT. (Q31119864) (← links)
- Four-dimensional cone beam CT with adaptive gantry rotation and adaptive data sampling (Q31132720) (← links)
- An efficient dose calculation strategy for intensity modulated proton therapy (Q33274044) (← links)
- Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers (Q33275432) (← links)
- Utility of four-dimensional computed tomography for analysis of intrafractional and interfractional variation in lung volumes (Q33362709) (← links)
- Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer (Q33400176) (← links)
- Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes (Q33615813) (← links)
- Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial (Q33645532) (← links)
- Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer (Q33674304) (← links)
- Exploration of the potential of liquid scintillators for real-time 3D dosimetry of intensity modulated proton beams (Q33703151) (← links)
- Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma (Q33809120) (← links)
- Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. (Q33809126) (← links)
- Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. (Q33809135) (← links)
- Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun (Q33843608) (← links)
- Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer (Q33860897) (← links)
- A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials (Q33920822) (← links)
- Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams (Q34081025) (← links)
- The risk of developing a second cancer after receiving craniospinal proton irradiation (Q34086830) (← links)
- Contemporary Proton Therapy Systems Adequately Protect Patients from Exposure to Stray Radiation (Q34125730) (← links)
- An MCNPX Monte Carlo model of a discrete spot scanning proton beam therapy nozzle (Q34137702) (← links)
- Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy (Q34138157) (← links)
- Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. (Q34161145) (← links)
- Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer (Q34187098) (← links)
- Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice (Q34228231) (← links)
- Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model (Q34238364) (← links)
- Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer (Q34695886) (← links)
- Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer (Q34739888) (← links)
- Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer (Q35050966) (← links)
- Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers (Q35163969) (← links)
- Estimation of α/β for Late Rectal Toxicity Based on RTOG 94-06 (Q35186584) (← links)
- Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer (Q35216097) (← links)
- Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients (Q35449770) (← links)
- Robust optimization of intensity modulated proton therapy (Q35764013) (← links)
- Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment (Q35933778) (← links)
- New strategies in radiation therapy: exploiting the full potential of protons (Q35990699) (← links)
- Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration (Q36094562) (← links)
- Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer (Q36105956) (← links)
- Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer (Q36133461) (← links)
- Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. (Q36143504) (← links)
- Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. (Q36145910) (← links)
- Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer (Q36151043) (← links)
- Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material (Q36171596) (← links)
- HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer (Q36185983) (← links)
- Analysis of radiation pneumonitis risk using a generalized Lyman model (Q36235629) (← links)
- Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. (Q36294010) (← links)